NCT02314871
- Conditions
- Colon Cancer, Colonic Diseases, Colonic Neoplasms, +14 more
- Locations
-
- Brno University Hospital Brno, South Moravian, Czechia
- T. Bata Regional Hospital Zlin Zlin, South Moravian, Czechia
Clinical trial condition
Minimal Residual Disease
Explore clinical trials studying Minimal Residual Disease. Study availability and eligibility vary by location and protocol.
48 public trials
20 recruiting studies
Minimal Residual Disease trial results
NCT02714790
- Conditions
- Acute Myeloid Leukemia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +25 more
- Locations
-
Not specified
NCT00267085
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +14 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
NCT03516279
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +15 more
- Locations
-
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
- Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
Active, Not Recruiting
Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell Malignancies
NCT03241940
- Conditions
- B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CD19 Positive, +29 more
- Locations
-
- Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
Active, Not Recruiting
Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
NCT03192397
- Conditions
- Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Complete Remission, Anemia, +45 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Active, Not Recruiting
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies
NCT03233854
- Conditions
- B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CD19 Positive, +22 more
- Locations
-
- Stanford University, School of Medicine Palo Alto, California, United States
Active, Not Recruiting
Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
NCT02159495
- Conditions
- Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Adult Acute Lymphoblastic Leukemia, +35 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States